Home
About
Product
magNews
Career
Contact Us
中文
English
Search News
Corporate
Industry
Technology
Medical Updates
end-stage heart failure
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD
2022-08-24
Industry
Behind the World's First Pig Heart Transplant - What Have We Learned?
2022-01-14
Corporate
magAssist was awarded the title of "Venture 100 Future Unicorn"
2021-12-17
Medical Updates
Professor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation"
2021-07-30
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference
2021-07-16
Technology
The Organ Care System jointly developed by Wuhan Union Hospital and magAssist has ushered in a breakthrough
2021-07-05
Medical Updates
Big country Great Medic|Nianguo Dong's team, pioneer of heart transplantation in China
2021-06-09
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device”
2023-01-06
Corporate
Highlights|magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application
2022-12-12
Corporate
Suzhou City leaders led a team to observe key projects in Suzhou High-tech Zone and learn more about the development of magAssist
2021-09-06
1
1/1
Tabs:
pVAD,
cardiogenic shock,
external life support systems,
ECMO devices,
IABP,
Bridge-to-recovery,
cardiogenic shock treatment,
MoyoAssist Extra-VAD,
solid technology of artificial hearts,
Awards,
TOP